SRX Global Inc. develops artificial intelligence (AI)-powered solutions designed to improve decision-making, streamline operations, and strengthen risk management. The company is headquartered in Tampa, Florida.
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
SRX Global announced it is liquidating its portfolio holdings in Vistagen Therapeutics and Greenland Mines, the filer of this release.
SRX simultaneously added an investment in Onconetix, which has a pending agreement to acquire Realbotix LLC, developer of robotic eyeball hardware and the Vinci AI Vision System.
For GRML shareholders the relevant fact is the divestiture of a stated shareholder position; no transaction size, proceeds, or GRML-specific figures were disclosed.